Characteristics of CML transplanted patients in first chronic phase (CP1) prior to HCT
Study #: CK21-R1
Study Status: Published
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia.
Baccarani M, Bonifazi F, Soverini S, Castagnetti F, Gugliotta G, Saber W, Estrada-Merly N, Rosti G, Gale RP.
Leukemia. 2022, May 01: 36(5): 36(5):1227-1236. doi: 10.1038/s41375-022-01522-3. Epub 2022, Mar 25. PMCID:PMC9061294.
PMID: 35338251
Abstract